Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold


Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial


Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

A Hybrid Approach to Continuous Biomanufacturing of Biosimilars

Presented by Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech
19th January 2023


A Versatile Solution for Host Cell Proteins (HCPs) and Aggregates Removal for mAbs Purification

Presented by Catherine Allioux & Gareth Leach, Ph.D
08th June 2017


Points To Consider: Demonstrating Comparability Between Recombinant and Lysate Reagent For BET Testing

Presented by Karen Zink McCullough, Owner, Principal Consultant at MMI Associates, Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories and Veronika Wills, Manager, Technical Services At Associates of Cape Cod, Inc
09th September 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia